Talzenna bags EU approval for gBRCA-mutated breast cancer

An important milestone in breast cancer treatment has been reached as the European Commission announced the approval of Pfizer’s Talzenna for patients with inherited BRCA-mutated locally advanced or metastatic breast cancer.

To learn more about this important approval, click the link below:

http://www.pharmatimes.com/news/talzenna_bags_eu_approval_for_gbrca-mutated_breast_cancer_1292259?fbclid=IwAR0vDYAm_zBuOopYI69k2izCEkeU_kHgKbqTKroxOmAG5pmf2l9RZTujRE4

Share This Article

Breast Cancer Ireland

Lower Ground Floor
Breast Cancer Ireland
77 Merrion Square South
Dublin 2

Email: info@breastcancerireland.com
Tel: 00353-1-5160331

Charity No: Chy 19926

Breast Cancer Ireland has been incorporated as Breast Cancer Ireland CLG, trading as: Breast Cancer Ireland

X